We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+8%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$181M
AUM Growth
+$14.5M
Cap. Flow
+$68.4K
Cap. Flow %
0.04%
Top 10 Hldgs %
46.73%
Holding
61
New
30
Increased
7
Reduced
10
Closed
12

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$7.19M
2
CI icon
Cigna
CI
+$6.79M
3
HUM icon
Humana
HUM
+$5.21M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$4.98M
5
HCA icon
HCA Healthcare
HCA
+$4.54M

Top Sells

Rank Stock Value
1
GYRE icon
Gyre Therapeutics
GYRE
+$15.9M
2
SNY icon
Sanofi
SNY
+$10.2M
3
BIIB icon
Biogen
BIIB
+$8.73M
4
VKTX icon
Viking Therapeutics
VKTX
+$6.62M
5
LLY icon
Eli Lilly
LLY
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 83.09%
2 Miscellaneous 10.77%
3 Financials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
1
Kura Oncology
KURA
$1.13B
$15.2M 8.43%
837,604
+180,193
+27% +$3.05M
ELV icon
2
Elevance Health
ELV
$85.5B
$10.4M 5.74%
43,601
-8,786
-17% -$2.03M
HCA icon
3
HCA Healthcare
HCA
$90.5B
$9.98M 5.52%
97,230
+44,900
+86% +$4.54M
LITS
4
Lite Strategy Inc
LITS
$33.4M
$8.61M 4.76%
109,199
+62,471
+134% +$3.83M
ICLR icon
5
Icon
ICLR
$13.1B
$7.33M 4.05%
55,332
+19,132
+53% +$2.38M
AET
6
DELISTED
Aetna Inc
AET
$7.18M 3.97%
39,135
+7,500
+24% +$1.34M
DB icon
7
PUT
Deutsche Bank
DB
$75.8B
$6.95M 3.84%
+654,800
New +$8.35M
CI icon
8
Cigna
CI
$73.7B
$6.66M 3.68%
+39,200
New +$6.79M
CAH icon
9
Cardinal Health
CAH
$54.6B
$6.19M 3.42%
+126,770
New +$7.19M
SNY icon
10
Sanofi
SNY
$107B
$6M 3.32%
150,058
-258,563
-63% -$10.2M
BSX icon
11
Boston Scientific
BSX
$67.9B
$5.97M 3.3%
182,633
-42,830
-19% -$1.29M
GYRE icon
12
Gyre Therapeutics
GYRE
$699M
$5.5M 3.04%
62,860
-90,472
-59% -$15.9M
HUM icon
13
Humana
HUM
$46.3B
$5.3M 2.93%
+17,793
New +$5.21M
PHG icon
14
Philips
PHG
$26.1B
$4.3M 2.38%
131,075
+29,974
+30% +$958K
NVS icon
15
Novartis
NVS
$292B
$4.16M 2.3%
+61,380
New +$4.24M
RIGL icon
16
Rigel Pharmaceuticals
RIGL
$868M
$3.96M 2.19%
+139,862
New +$4.98M
WTW icon
17
Willis Towers Watson
WTW
$31.9B
$3.94M 2.18%
+25,969
New +$3.95M
UHS icon
18
Universal Health Services
UHS
$10.1B
$3.94M 2.18%
+35,323
New +$4.14M
RVTY icon
19
Revvity
RVTY
$14.4B
$3.85M 2.13%
+52,620
New +$3.95M
PFE icon
20
PUT
Pfizer
PFE
$159B
$3.63M 2.01%
+105,400
New +$3.6M
VTRS icon
21
CALL
Viatris
VTRS
$18.8B
$3.61M 2%
+100,000
New +$3.92M
ECOR icon
22
electroCore
ECOR
$86.8M
$3.52M 1.95%
+14,241
New +$3.87M
CELG
23
DELISTED
Celgene Corp
CELG
$3.33M 1.84%
41,942
+10,762
+35% +$894K
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3.01M 1.66%
+143,550
New +$2.66M
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.96M 1.64%
+60,050
New +$2.27M
1
2 3

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Sio Capital Management held 61 positions worth $181M, up 8.7% from $166M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sio Capital Management's Q2 2018 filing shows 30 new, 7 increased, 10 reduced and 12 closed positions. Its largest new stake was Cardinal Health: 126,770 shares worth $6.19M. The largest sale was Gyre Therapeutics, an estimated $15.9M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 93% a quarter earlier, followed by Miscellaneous and Financials.

  • Sio Capital Management's largest Q2 2018 buy was Cardinal Health: 126,770 shares worth $6.19M.
  • Sio Capital Management added most to HCA Healthcare in Q2 2018, an estimated $4.54M increase.
  • Sio Capital Management's biggest Q2 2018 reduction was Gyre Therapeutics, cutting an estimated $15.9M.
  • Sio Capital Management fully exited Biogen in Q2 2018, selling an estimated $8.73M.
  • Sio Capital Management's ten largest holdings make up 47% of its $181M portfolio in Q2 2018.
  • Sio Capital Management opened 30 new positions and closed 12 in Q2 2018.
  • Sio Capital Management's portfolio value rose 8.7% quarter-over-quarter to $181M.

Based on Sio Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.